
太空与生物技术研究融合将为地球带来哪些新的可能?
随着阿尔忒弥斯2号任务的启动,人类宇航员时隔50多年再次踏入深空,这不仅宣告着载人航天新纪元的到来,更预示着一个大趋势——航天技术与生物技术正在加速融合。
Accomplished venture capital investor with a proven track record. Focusing on AI + Life Science/Healthcare. Extensive network spans across senior executives, academic leaders and syndicate investors. She is also a passionate venture builder with solid 0-to-1 incubation experience, taking innovations from patents to market by designing strategies, supporting capital raises and assembling high-performing teams. Before her venture capital career, Qing was a physician at Singapore General Hospital and a researcher at Broad Institute. She holds M.D. at Tsinghua University and MBA from Columbia Business School.
随着阿尔忒弥斯2号任务的启动,人类宇航员时隔50多年再次踏入深空,这不仅宣告着载人航天新纪元的到来,更预示着一个大趋势——航天技术与生物技术正在加速融合。
The recent Artemis II mission returned astronauts to deep space for the first time in over 50 years, bringing human space flight to a new phase. It also signaled something broader – the g...
人类正步入一个生物学与计算科学融合的时代。生成式人工智能已经成为推动生命科学进展的最强大的加速剂之一,并扩大了CRISPR和细胞工程等其他生物技术的发展成果。
La humanidad está entrando en una era en la que la biología y la computación convergen. La inteligencia artificial generativa (GenAI) ha surgido como uno de los catalizadores más poderoso...
Humanity is entering an era where biology and computation are converging. Generative artificial intelligence (GenAI) has emerged as one of the most powerful catalysts accelerating progres...


